Nuvothera

Nuvothera

Empowering relief for chronic inflammatory disorders with innovative over-the-counter solutions.

Founded 2014 2-10 employees Seed Total: $2.06M Biotechnology, Health Care

Nuvothera is a biotechnology and healthcare startup founded in 2014, with a focus on providing innovative over-the-counter solutions for chronic inflammatory disorders. The company's product line includes a topical daily psoriasis management system and a nutritional supplement called Nuvothera Super-MicronizedTM Turmeric Curcumin, specifically designed for managing conditions such as psoriasis and difficult skin issues. Their slogan, "Empowering relief for chronic inflammatory disorders with innovative over-the-counter solutions," encapsulates their mission. Nuvothera's most recent milestone was the Seed Round investment on November 14, 2022, led by Seed Round Capital, signaling confidence and support from investors. This investment is poised to propel Nuvothera's innovations and expansion further into the healthcare market, offering potential for significant industry impact. As Nuvothera continues to develop its range of solutions, addressing unmet needs in chronic inflammatory disorders, its strategic focus on over-the-counter products places it at the forefront of accessible and effective healthcare solutions.

Funding Stage	Amount	Investors	Lead Investors	Date
Seed Round	Undisclosed	1	Seed Round Capital	14 Nov 2022
Venture Round	$2.06M	-		16 Feb 2018

Funding Stage

Amount

Investors

Lead Investors

Date

Seed Round

Undisclosed

Seed Round Capital

14 Nov 2022

Venture Round

$2.06M

16 Feb 2018

FAQ About Nuvothera

Empowering relief for chronic inflammatory disorders with innovative over-the-counter solutions.

Nuvothera was founded in 2014.

Nuvothera operates in Biotechnology and Health Care. Its work centres on chronic inflammatory disorders, over-the-counter solutions, topical psoriasis management and skin care.

Nuvothera has approximately 2-10 employees.

Nuvothera has completed 2 funding rounds, raising a total of $2.06M. The latest funding stage is Seed.

Top alternatives and competitors to Nuvothera include Brighter, Abacus Health Products, Ivivi Technologies, Dermatology & Skin Surgery Specialists, Evommune. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Nuvothera and Brighter are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Nuvothera

Funding Rounds & Investors (2)

Nuvothera Alternatives & Competitors

FAQ About Nuvothera